Ibrutinib-naïve chronic lymphocytic leukemia lacks Bruton tyrosine kinase mutations associated with treatment resistance

Rosella Famà, Riccardo Bomben, Silvia Rasi, Michele Dal Bo, Carmela Ciardullo, Sara Monti, Francesca Rossi, Tiziana D Agaro, Antonella Zucchetto, Valter Gattei, Gianluca Gaidano, Davide Rossi

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)3831-3832
Number of pages2
JournalBlood
Volume124
Issue number25
DOIs
Publication statusPublished - Dec 11 2014

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology
  • Medicine(all)

Cite this

Famà, R., Bomben, R., Rasi, S., Bo, M. D., Ciardullo, C., Monti, S., Rossi, F., D Agaro, T., Zucchetto, A., Gattei, V., Gaidano, G., & Rossi, D. (2014). Ibrutinib-naïve chronic lymphocytic leukemia lacks Bruton tyrosine kinase mutations associated with treatment resistance. Blood, 124(25), 3831-3832. https://doi.org/10.1182/blood-2014-08-592725